Navigation Links
Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Ventrus Biosciences, Inc.
Date:5/10/2013

NEW YORK, May 10, 2013 /PRNewswire/ -- Bernstein Liebhard LLP today announced that a class action has been commenced in the United States District Court for the Southern District of New York on behalf of a class (the "Class") of purchasers of Ventrus Biosciences, Inc. ("Ventrus" or the "Company") (NASDAQ: VTUS) securities between December 17, 2010 and June 25, 2012 (the "Class Period").

(Logo: http://photos.prnewswire.com/prnh/20120202/MM47134LOGO

Ventrus is a development stage pharmaceutical company which is focused on late-stage prescription drugs for the treatment of gastrointestinal disorders, specifically hemorrhoids, anal fissures, and fecal incontinence.  Ventrus' lead products are topical treatments for hemorrhoids, which target a specific serotonin receptor.

Plaintiffs allege that, throughout the Class Period, the Company made false and/or misleading statements, as well as failed to disclose material adverse facts concerning the Company's lead product iferanserin (VEN 309) ("VEN 309").  The Company described VEN 309 as a new chemical entity for the topical treatment of symptomatic internal hemorrhoids.  The Company stated that in seven clinical studies between 1993 and 2003, VEN 309 demonstrated good tolerability and no severe adverse events while showing statistically significant improvements in bleeding, itchiness, and pain.

Specifically, during the Class Period the Company stated that it was in frequent and ongoing communications with the FDA, that clinical end points for the VEN 309 trial had been agreed to by the FDA, and that the prior results from Phase II trials of VEN 309 demonstrated the product's clinical efficacy. The Company represented its prior Phase I
'/>"/>

SOURCE Bernstein Liebhard LLP
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Bernstein Liebhard LLP Announces That A Securities Class Action Has Been Filed Against Aveo Pharmaceutical, Inc.
2. The law firms of Bernstein Litowitz Berger & Grossmann LLP and Labaton Sucharow LLP announce pendency of class action in In re Schering-Plough Corporation / ENHANCE Securities Litigation
3. Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Abiomed, Inc.
4. Par Pharmaceutical Companies, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By TPG
5. Amylin Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Bristol-Myers Squibb Company
6. Watson to Present at the Sanford C. Bernstein 28th Annual Strategic Decisions Conference
7. Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma
8. Echo Therapeutics Announces First Quarter 2013 Financial Results
9. Life Care Medical Devices Ltd Announces Addition Of Dublin, Ireland Based European Subsidiary
10. Creabilis Announces Headline Results of its Phase 2b Trial of Topical TrkA Kinase Inhibitor CT327
11. Omeros Announces $16.2 Million Registered Direct Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... WARSAW, Ind., July 24, 2014 Zimmer Holdings, ... for the quarter ended June 30, 2014.  The Company ... increase of 1.2% reported and 0.9% constant currency over ... for the quarter were $1.03 reported and $1.49 adjusted, ... period. "The second quarter was marked ...
(Date:7/24/2014)... , July 24, 2014 ... today announced that it has been selected ... non-profit organization with membership representation from 19 ... subscription-based platform that will transform the way ... clinical trials. TransCelerate BioPharma Inc. is dedicated ...
(Date:7/23/2014)... -- Varian Medical Systems (NYSE: VAR ) today ... in the third quarter of fiscal year 2014.  Net ... share due to an approximately $8 million impairment charge ... in Augmenix, a privately-held company developing minimally invasive hydrogels ... the third quarter of fiscal year 2014, up 3 ...
Breaking Medicine Technology:Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 2Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 3Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 4Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 5Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 6Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 7Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 8Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 9Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 10Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 11Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 12Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 13Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 14Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 15Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 16Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 17Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 18Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 19Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 20Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 21Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 22Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 23Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 24TransCelerate Selects Cognizant to Develop a Clinical Trials Collaboration Platform 2TransCelerate Selects Cognizant to Develop a Clinical Trials Collaboration Platform 3TransCelerate Selects Cognizant to Develop a Clinical Trials Collaboration Platform 4TransCelerate Selects Cognizant to Develop a Clinical Trials Collaboration Platform 5Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 2Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 3Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 4Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 5Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 6Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 7Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 8Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 9
... NDA for Ondansetron Orally Dissolving Film StripBioAlliance to Resubmit ... Pharmaceuticals, the proprietary products division of a wholly owned ... PRX ), today provides an update on two of ... Strip On April 7, 2009, Strativa submitted a New ...
... April 7 Scientists at Schepens Eye Research Institute ... is essential to the health of blood vessels in ... dysfunction. These findings, published in the April 2 issue ... the prevention and treatment of diseases such as diabetic ...
Cached Medicine Technology:Strativa Pharmaceuticals Provides Product Pipeline Update 2Strativa Pharmaceuticals Provides Product Pipeline Update 3Strativa Pharmaceuticals Provides Product Pipeline Update 4Scientists Discover a Role for the Growth Factor TGF-beta in Maintaining Health of Retinal Blood Vessels 2Scientists Discover a Role for the Growth Factor TGF-beta in Maintaining Health of Retinal Blood Vessels 3
(Date:7/24/2014)... July 24, 2014 At the Case ... Conference & Expo on July 17 – 20, 2014, ... awards for individuals, organizations, and chapter recipients. , ... Dr. Michael Anderson, Vice President and Chief Medical Officer ... Officer for Cleveland Clinic; and Cleveland Mayor Frank G. ...
(Date:7/24/2014)... NV (PRWEB) July 24, 2014 The ... 9:00 am EDT, An archived recorded version can be ... http://www.stocktraderstalk.com , following the interview. , This ... Division which provides commercial quality, advanced, digital security solutions ... and SOX and their CipherLoc product suite offers both ...
(Date:7/24/2014)... July 24, 2014 Catholic Health Partners ... Health Partners, has changed its name to Mercy Health. ... evolution to one unified team, focused on high-quality care, ... Ohio’s largest health system and fourth-largest employer. , “Our ... we are working together to improve the health of ...
(Date:7/24/2014)... 24, 2014 Texas Physical Therapy ... announce the installation of the AlterG Anti-Gravity Treadmill ... professional athletes to continue training stress-free while recovering from ... clinic in July 2014, uses technology created by NASA ... up to 80% of the weight normally included in ...
(Date:7/24/2014)... (PRWEB) July 24, 2014 6 Minutes ... kicking its metabolism into high gear with only a ... changes to one’s diet or lifestyle. This has caught ... review. , “Our 6 Minutes to Skinny review ... taken the time to understand exactly how your body ...
Breaking Medicine News(10 mins):Health News:CMSA Presents 2014 National Case Management Awards at Annual Conference & Expo 2Health News:CMSA Presents 2014 National Case Management Awards at Annual Conference & Expo 3Health News:CMSA Presents 2014 National Case Management Awards at Annual Conference & Expo 4Health News:Cloud Medical Doctor Software Corporation, CEO, Michael DeLaGarza, Exclusive Interview on StockTradersTalk.com 2Health News:Cloud Medical Doctor Software Corporation, CEO, Michael DeLaGarza, Exclusive Interview on StockTradersTalk.com 3Health News:HMHP’s Parent, Catholic Health Partners, Changes Name to Mercy Health 2Health News:HMHP’s Parent, Catholic Health Partners, Changes Name to Mercy Health 3Health News:HMHP’s Parent, Catholic Health Partners, Changes Name to Mercy Health 4Health News:Texas Physical Therapy Specialists Helps Patients Recover With AlterG Anti-Gravity Treadmill 2Health News:6 Minutes to Skinny: Review Examining Craig Ballantyne’s Weight Loss Program Released 2Health News:6 Minutes to Skinny: Review Examining Craig Ballantyne’s Weight Loss Program Released 3
... , , WASHINGTON , ... Center hosts a symposium exploring the future of cancer research on ... (GUMC).  Sponsored by the Ruesch Center for the Cure of Gastrointestinal ... Personalized Medicine & the Cure for Cancer, " will offer a ...
... Mo. , Feb. 12 The Reliv Kalogris ... $450,000 worth of children,s nutritional supplements to Haitian ... 3,000 cases of Reliv Now for Kids, a supplement containing ... to strengthen children,s health. Reliv produces nutritional supplements that are ...
... February 12, 2010 Giving chocolates to your Valentine on ... on a preliminary study from researchers at St. Michael,s Hospital. ... of Neurology in April, also found that eating chocolate may ... "Though more research is needed to determine whether chocolate is ...
... , Medication Delivered Under the Tongue May Be Alternative ... An oral allergy treatment administered in drops under the tongue ... are allergic to ragweed pollen, according to a study published today ... specialist at Allegheny General Hospital.   , Widely used in ...
... , 75% Say the U.S. ... Feb. 12 More than half (57%) of registered American voters ... Afghanistan , and half (52%) also approve of the way ... of the way the president is dealing with the country,s economic ...
... , THE WOODLANDS, Texas , Feb. 12 ... staff interested in learning the most important aspects to be aware ... for your particular practice are invited to attend a free webinar ... on Thursday, Feb. 18, 2010 . To register, ...
Cached Medicine News:Health News:GUMC's Lombardi Hosts Symposium Exploring Future of Cancer Research and Personalized Medicine 2Health News:GUMC's Lombardi Hosts Symposium Exploring Future of Cancer Research and Personalized Medicine 3Health News:Reliv Foundation Donates $450,000 In Nutritional Supplements to Haitian Relief Efforts 2Health News:Reliv Foundation Donates $450,000 In Nutritional Supplements to Haitian Relief Efforts 3Health News:Allegheny General Hospital Study Demonstrates Safety and Potential Efficacy of Oral Allergy Treatment 2Health News:Majority of Americans Approve of President Obama's Handling of Afghanistan and National Security But Disapprove of Handling of Economic Issues, Per Franklin & Marshall College Poll With Hearst Television 2Health News:Majority of Americans Approve of President Obama's Handling of Afghanistan and National Security But Disapprove of Handling of Economic Issues, Per Franklin & Marshall College Poll With Hearst Television 3Health News:Majority of Americans Approve of President Obama's Handling of Afghanistan and National Security But Disapprove of Handling of Economic Issues, Per Franklin & Marshall College Poll With Hearst Television 4Health News:What to Look for When Selecting an Electronic Health Record for Your Community Oncology Practice - Free Educational Webinar 2Health News:What to Look for When Selecting an Electronic Health Record for Your Community Oncology Practice - Free Educational Webinar 3
The Buechel-pappas™ Total Ankle Replacement is a time-tested system which is the result of more than twenty years of development, clinical investigation, and use. The components have been avai...
The Assistant Free Self-Retaining Hip Surgery Retractor System is used for hip arthroplasty and hip fracture surgery....
The Endotrac™ System includes an Obturator, Slotted Cannula, Synovial Elevator, Ligament Probe, Ligament Rasp, Blade Handle, two Retractors and sterilizable tray. The Endotrac&trade....
Low-profile hand-held instruments....
Medicine Products: